Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis
A Auricchio, JH Hudnall, EJ Schloss, LD Sterns… - EP …, 2017 - academic.oup.com
Abstract Aims Single-chamber (VR-ICD) and subcutaneous (S-ICD) implantable cardioverter-
defibrillators are effective to protect patients against sudden death but expose them to higher …
defibrillators are effective to protect patients against sudden death but expose them to higher …
Competitive athletes with implantable cardioverter–defibrillators—How to program? Data from the Implantable Cardioverter–Defibrillator Sports Registry
B Olshansky, G Atteya, D Cannom, H Heidbuchel… - Heart Rhythm, 2019 - Elsevier
Background Athletes with an implantable cardioverter–defibrillator (ICD) may require unique
optimal device-based tachycardia programming. Objective The purpose of this study was to …
optimal device-based tachycardia programming. Objective The purpose of this study was to …
Long detection programming in single-chamber defibrillators reduces unnecessary therapies and mortality: the ADVANCE III trial
M Gasparini, MG Lunati, A Proclemer, A Arenal… - JACC: Clinical …, 2017 - jacc.org
Objectives: This study sought to evaluate the effects of programming a long detection in
single-chamber (VVI) implantable cardioverter-defibrillators (ICDs) in the multicenter …
single-chamber (VVI) implantable cardioverter-defibrillators (ICDs) in the multicenter …
The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy
L Dinshaw, J Münch, J Dickow, S Lezius… - Clinical Research in …, 2018 - Springer
Introduction Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of
sudden cardiac death (SCD) primarily due to ventricular arrhythmia (VA). In patients (pts.) …
sudden cardiac death (SCD) primarily due to ventricular arrhythmia (VA). In patients (pts.) …
Impact of Age on Subcutaneous Implantable Cardioverter-Defibrillator in a Large Patient Cohort: Mid-Term Follow-Up
R Weiss, BP Knight, M El-Chami, J Aasbo… - Clinical …, 2023 - jacc.org
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an accepted
alternative to transvenous (TV) ICD to provide defibrillation therapy to treat life-threatening …
alternative to transvenous (TV) ICD to provide defibrillation therapy to treat life-threatening …
Device therapies among patients receiving primary prevention implantable cardioverter‐defibrillators in the Cardiovascular research network
RT Greenlee, AS Go, PN Peterson… - Journal of the …, 2018 - Am Heart Assoc
Background Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …
Right versus left parasternal electrode position in the entirely subcutaneous ICD
M Bettin, D Dechering, G Frommeyer, R Larbig… - Clinical Research in …, 2018 - Springer
Objectives The subcutaneous implantable cardioverter defibrillator (S-ICD®) has been
established as an alternative to conventional transvenous ICD for the prevention of sudden …
established as an alternative to conventional transvenous ICD for the prevention of sudden …
Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study
JC Geller, A Wöhrle, M Busch, A Elsässer… - Journal of Interventional …, 2021 - Springer
Purpose Inappropriate implantable cardioverter-defibrillator (ICD) shocks are associated
with greater healthcare resource utilization, poorer quality-of-life, and higher mortality. We …
with greater healthcare resource utilization, poorer quality-of-life, and higher mortality. We …
Adekvátní a neadekvátní terapie u pacientů s implantabilním kardioverterem‑defibrilátorem
D Kiss, M Kozák, M Sepši, P Kala - Vnitřní lékařství, 2021 - casopisvnitrnilekarstvi.cz
Implantabilní kardiovertery‑defibrilátory (ICD) snižují mortalitu pacientů s rizikem náhlé
srdeční smrti v primární i sekundární prevenci. U pacientů indikovaných k implantaci se …
srdeční smrti v primární i sekundární prevenci. U pacientů indikovaných k implantaci se …
Decreased inappropriate shocks with new generation ICDs in children and patients with congenital heart disease
SA Goldstein, MJ LaPage, BE Dechert… - Congenital Heart …, 2018 - Wiley Online Library
Objective Inappropriate implantable cardioverter defibrillator (ICD) shocks in children and
patients with congenital heart disease (CHD) remain a major complication of device therapy …
patients with congenital heart disease (CHD) remain a major complication of device therapy …